FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3214720516> ?p ?o ?g. }

• W3214720516 endingPage "1878" @default.
• W3214720516 startingPage "1868" @default.
• W3214720516 abstract "ABSTRACT Background Chronic kidney disease (CKD) patients are at high-risk for severe coronavirus disease 2019 (COVID-19). The multicentric, observational and prospective SENCOVAC study aims to describe the humoral response and safety of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in CKD patients. Safety and immediate humoral response results are reported here. Methods Four cohorts of patients were included: kidney transplant (KT) recipients, and haemodialysis (HD), peritoneal dialysis (PD) and non-dialysis CKD patients from 50 Spanish centres. Adverse events after vaccine doses were recorded. At baseline and on Day 28 after the last vaccine dose, anti-Spike antibodies were measured and compared between cohorts. Factors associated with development of anti-Spike antibodies were analysed. Results A total of 1746 participants were recruited: 1116 HD, 171 PD, 176 non-dialysis CKD patients and 283 KT recipients. Most patients (98%) received mRNA vaccines. At least one vaccine reaction developed after the first dose in 763 (53.5%) and after the second dose in 741 (54.5%) of patients. Anti-Spike antibodies were measured in the first 301 patients. At 28 days, 95% of patients had developed antibodies: 79% of KT, 98% of HD, 99% of PD and 100% of non-dialysis CKD patients (P &lt; 0.001). In a multivariate adjusted analysis, absence of an antibody response was independently associated with KT (odds ratio 20.56, P = 0.001) and with BNT162b2 vaccine (odds ratio 6.03, P = 0.023). Conclusion The rate of anti-Spike antibody development after vaccination in KT patients was low but in other CKD patients it approached 100%, suggesting that KT patients require persistent isolation measures and booster doses of a COVID-19 vaccine. Potential differences between COVID-19 vaccines should be explored in prospective controlled studies." @default.
• W3214720516 created "2021-11-22" @default.
• W3214720516 creator A5000294510 @default.
• W3214720516 creator A5005031266 @default.
• W3214720516 creator A5005549802 @default.
• W3214720516 creator A5024758109 @default.
• W3214720516 creator A5027926335 @default.
• W3214720516 creator A5029720078 @default.
• W3214720516 creator A5036646028 @default.
• W3214720516 creator A5041313199 @default.
• W3214720516 creator A5053327378 @default.
• W3214720516 creator A5056496410 @default.
• W3214720516 creator A5058026485 @default.
• W3214720516 creator A5063245254 @default.
• W3214720516 creator A5066063263 @default.
• W3214720516 creator A5071593060 @default.
• W3214720516 creator A5075077497 @default.
• W3214720516 creator A5077117424 @default.
• W3214720516 creator A5078629962 @default.
• W3214720516 creator A5084588134 @default.
• W3214720516 creator A5090288416 @default.
• W3214720516 date "2021-11-12" @default.
• W3214720516 modified "2023-10-18" @default.
• W3214720516 title "Safety and immediate humoral response of COVID-19 vaccines in chronic kidney disease patients: the SENCOVAC study" @default.
• W3214720516 cites W1990496124 @default.
• W3214720516 cites W2104843066 @default.
• W3214720516 cites W3047144258 @default.
• W3214720516 cites W3113930329 @default.
• W3214720516 cites W3150786652 @default.
• W3214720516 cites W3155756133 @default.
• W3214720516 cites W3158103490 @default.
• W3214720516 cites W3158948419 @default.
• W3214720516 cites W3165514001 @default.
• W3214720516 cites W3165884098 @default.
• W3214720516 cites W3170039809 @default.
• W3214720516 cites W3176897911 @default.
• W3214720516 cites W3177852708 @default.
• W3214720516 cites W3184002959 @default.
• W3214720516 cites W3184172540 @default.
• W3214720516 cites W3184847754 @default.
• W3214720516 cites W3186535828 @default.
• W3214720516 cites W3189226048 @default.
• W3214720516 cites W3190889496 @default.
• W3214720516 cites W3194347237 @default.
• W3214720516 cites W3196026921 @default.
• W3214720516 cites W3204661328 @default.
• W3214720516 doi "https://doi.org/10.1093/ndt/gfab313" @default.
• W3214720516 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34788858" @default.
• W3214720516 hasPublicationYear "2021" @default.
• W3214720516 type Work @default.
• W3214720516 sameAs 3214720516 @default.
• W3214720516 citedByCount "36" @default.
• W3214720516 countsByYear W32147205162021 @default.
• W3214720516 countsByYear W32147205162022 @default.
• W3214720516 countsByYear W32147205162023 @default.
• W3214720516 crossrefType "journal-article" @default.
• W3214720516 hasAuthorship W3214720516A5000294510 @default.
• W3214720516 hasAuthorship W3214720516A5005031266 @default.
• W3214720516 hasAuthorship W3214720516A5005549802 @default.
• W3214720516 hasAuthorship W3214720516A5024758109 @default.
• W3214720516 hasAuthorship W3214720516A5027926335 @default.
• W3214720516 hasAuthorship W3214720516A5029720078 @default.
• W3214720516 hasAuthorship W3214720516A5036646028 @default.
• W3214720516 hasAuthorship W3214720516A5041313199 @default.
• W3214720516 hasAuthorship W3214720516A5053327378 @default.
• W3214720516 hasAuthorship W3214720516A5056496410 @default.
• W3214720516 hasAuthorship W3214720516A5058026485 @default.
• W3214720516 hasAuthorship W3214720516A5063245254 @default.
• W3214720516 hasAuthorship W3214720516A5066063263 @default.
• W3214720516 hasAuthorship W3214720516A5071593060 @default.
• W3214720516 hasAuthorship W3214720516A5075077497 @default.
• W3214720516 hasAuthorship W3214720516A5077117424 @default.
• W3214720516 hasAuthorship W3214720516A5078629962 @default.
• W3214720516 hasAuthorship W3214720516A5084588134 @default.
• W3214720516 hasAuthorship W3214720516A5090288416 @default.
• W3214720516 hasBestOaLocation W32147205162 @default.
• W3214720516 hasConcept C126322002 @default.
• W3214720516 hasConcept C156957248 @default.
• W3214720516 hasConcept C159654299 @default.
• W3214720516 hasConcept C197934379 @default.
• W3214720516 hasConcept C203014093 @default.
• W3214720516 hasConcept C22070199 @default.
• W3214720516 hasConcept C2778063415 @default.
• W3214720516 hasConcept C2778653478 @default.
• W3214720516 hasConcept C2779056158 @default.
• W3214720516 hasConcept C2779978075 @default.
• W3214720516 hasConcept C71924100 @default.
• W3214720516 hasConceptScore W3214720516C126322002 @default.
• W3214720516 hasConceptScore W3214720516C156957248 @default.
• W3214720516 hasConceptScore W3214720516C159654299 @default.
• W3214720516 hasConceptScore W3214720516C197934379 @default.
• W3214720516 hasConceptScore W3214720516C203014093 @default.
• W3214720516 hasConceptScore W3214720516C22070199 @default.
• W3214720516 hasConceptScore W3214720516C2778063415 @default.
• W3214720516 hasConceptScore W3214720516C2778653478 @default.
• W3214720516 hasConceptScore W3214720516C2779056158 @default.
• W3214720516 hasConceptScore W3214720516C2779978075 @default.
• W3214720516 hasConceptScore W3214720516C71924100 @default.

• next